Trials / Conditions / Human Papilloma Virus Infection

Human Papilloma Virus Infection

32 registered clinical trials studyying Human Papilloma Virus Infection — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	Understanding Women's Values in Managing Human Papillomavirus (HPV) NCT06123533	University of Aberdeen	—
Unknown	Immunogenicity of 9-valent HPV Vaccine NCT05439083	Talia Sainz Costa	Phase 4
Recruiting	Effects of Chinese Medicine and Lactobacillus in Persistent HPV Infection NCT06467942	Peking University People's Hospital	N/A
Not Yet Recruiting	Diagnostic Cervical Conization for Persistent Infection or Integration of HPV NCT05510830	Tongji Hospital	N/A
Completed	Detection of High-Risk HPV in Urine and Cervical Swab Specimen Using HPV Diagnostic Kit (Bio Farma) NCT06111911	PT Bio Farma	N/A
Withdrawn	Reducing Abundance of Human Papilloma Virus in Women by Taking Probiotic NCT05316064	Universiti Sains Malaysia	Phase 2 / Phase 3
Completed	Papilocare®: Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and Toleranc NCT04624568	Centre Hospitalier Régional d'Orléans	N/A
Completed	A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine NCT05694728	Beijing Health Guard Biotechnology, Inc	Phase 2
Completed	Developing Methods to Investigate Additional Opportunities of HPV Vaccination by Using First-void Urine Sample NCT04391647	Universiteit Antwerpen	—
Completed	Prevalence of HPV-associated Eye Infection and Cytokine Levels in Tears From Patients Diagnosed With Pterygium NCT04117386	Chulalongkorn University	—
Completed	Clinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk L NCT04199078	Procare Health Iberia S.L.	N/A
Terminated	Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) NCT03677960	Antiva Biosciences	Phase 1
Completed	Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine NCT03542227	Universiteit Antwerpen	—
Completed	Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) NCT03202992	Antiva Biosciences	Phase 1
Completed	The HPV Self-test as a Test of Cure in Madagascar NCT02811367	University Hospital, Geneva	N/A
Completed	Community-Driven Cervical Cancer Prevention in Western Kenya NCT02124252	Duke University	N/A
Completed	Clinical Trial to Explore the Papilocare Gel Efficacy to Repair the Cervico-vaginal Mucosa With Lesions Caused NCT04002154	Procare Health Iberia S.L.	N/A
Completed	Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine (AB-S NCT02714114	Universiteit Antwerpen	—
Completed	Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions NCT02135419	AIDS Malignancy Consortium	Phase 3
Completed	Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or NCT02258659	University of Chicago	Phase 2
Active Not Recruiting	Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Trea NCT01898494	ECOG-ACRIN Cancer Research Group	Phase 2
Completed	Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Sta NCT02048020	Jonsson Comprehensive Cancer Center	Phase 2
Completed	Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV NCT01946139	AIDS Malignancy Consortium	N/A
Completed	Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles Count NCT02067507	University of California, Los Angeles	N/A
Completed	Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote NCT01539668	Barretos Cancer Hospital	—
Completed	Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ System NCT01446198	Gen-Probe, Incorporated	—
Active Not Recruiting	The Parents in Appalachia Receive Education Needed for Teen Project NCT01901770	Ohio State University Comprehensive Cancer Center	N/A
Completed	Post-Licensure Study of the Safety of GARDASIL™ in Males (V501-070) NCT01567813	Merck Sharp & Dohme LLC	—
Unknown	e- Ab Sensor-based Real-time Detection of Oncogenic Human Papilloma Viruses NCT01387997	National Taiwan University Hospital	N/A
Completed	Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimen NCT02634190	Hologic Deutschland GmbH	—
Completed	Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical I NCT00303823	National Cancer Institute (NCI)	Phase 2
Completed	Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia NCT00054041	National Cancer Institute (NCI)	Phase 2